Haolan Qi, MD
Dr. Qi is an MSc candidate in Epidemiology at McGill University. She earned her Medical Degree (MD) in China before pursuing her graduate studies in Canada. Her research primarily focuses on clinical pharmacoepidemiology, with a specific interest in evaluating the safety and effectiveness of pharmacological treatments for osteoporosis using large real-world databases. Dr. Qi is deeply dedicated to advancing clinical pharmacoepidemiology research, aiming to generate high-quality evidence that informs clinical decision-making, optimizes treatment strategies, and ultimately improves patient outcomes in the field of endocrinology.